139 studies found for:    Open Studies | "Fatty Liver"
Show Display Options
Rank Status Study
1 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
2 Recruiting Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Conditions: Hepatic Steatosis;   Fatty Liver
Intervention:
3 Unknown  Fatty Liver in Inflammatory Bowel Disease (IBD) Patients
Conditions: Inflammatory Bowel Disease;   Fatty Liver
Intervention: Other: clinical evaluation
4 Recruiting Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver
Condition: Fatty Liver
Intervention: Dietary Supplement: Probiotics and fruit fibre
5 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Dietary Supplement: Vitamin E 200 IU/d;   Dietary Supplement: Vitamin E 400 IU/d;   Dietary Supplement: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
6 Recruiting Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
Condition: Fatty Liver
Intervention:
7 Recruiting Insulin Resistance in Non-alcoholic Fatty Liver Disease
Condition: Fatty Liver
Interventions: Drug: fenofibrate;   Drug: pioglitazone;   Drug: placebo
8 Unknown  Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
Conditions: HIV Infections;   Fatty Liver
Interventions: Drug: antioxidant vitamin E;   Behavioral: weight reduction and exercise
9 Not yet recruiting Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Fish Oil Supplementation;   Drug: Placebo Supplementation
10 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
11 Recruiting Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Conditions: Insulin Resistance;   Nonalcoholic Fatty Liver Disease
Intervention:
12 Not yet recruiting Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty Liver
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Device: CPAP;   Behavioral: LIfestyle
13 Recruiting A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
Conditions: Psoriasis;   Nonalcoholic Fatty Liver Disease
Intervention:
14 Recruiting Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease;   Steatohepatitis;   Hypertriglyceridemia;   Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
Interventions: Dietary Supplement: Lovaza;   Other: Omega diet
15 Recruiting Dietary Intervention and Intestinal Microbiota in Non-alcoholic Fatty Liver
Conditions: Obesity;   Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Other: Hypocaloric diet
16 Unknown  The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: Omacor;   Drug: lactose tablet
17 Recruiting Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Procedure: Phlebotomy
18 Unknown  Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Lovaza;   Drug: placebo control
19 Recruiting Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease
Conditions: Obesity;   Nonalcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
20 Unknown  Study of Fish Oil to Reduce ALT Levels in Adolescents
Conditions: Non-Alcoholic Fatty Liver Disease;   Fatty Liver
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years